山河药辅(300452.SZ)：复星医药拟减持不超过3%股份

Core Viewpoint - Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. plans to reduce its stake in Shanhe Pharmaceutical Auxiliary Co., Ltd. by up to 6,978,729 shares, representing no more than 3% of the company's total share capital, excluding repurchased shares [1] Summary by Relevant Sections - Share Reduction Plan - The reduction will occur through centralized bidding and block trading methods within a period of 90 days starting from November 24, 2025, to February 21, 2026 [1] - Share Capital Details - The total shares to be reduced are calculated based on the company's total share capital, excluding 1,825,500 shares that have been repurchased [1]